Ebola therapies: an unconventionally calculated risk.
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
- Item Type
- Publication
- Terms of Use
- By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Stable Link to this Asset
Information about this resource
- Title
- Ebola therapies: an unconventionally calculated risk.
- Subject
- Research
- Description
- This article reviews the testing of Ebola therapies during the outbreak.
- Creator
- Fallah MP, Skrip LA.
- Date
- 2019-01-24
- Citation
- Fallah, M. P., and L. A. Skrip. 2019. "Ebola therapies: an unconventionally calculated risk." Lancet (London, England) 393 (10174):850-2.
- Abstract
- The current outbreak of Ebola virus disease in the Democratic Republic of the Congo, uninterrupted since August, 2018, is the largest to date in a country that has had nine outbreaks since 1976 and contained the virus each...
- Accessibility
- Free online on journal website. © 2019 Elsevier Ltd. All rights reserved.
Was this resource helpful?